Pablo Zapata Benavides

Dr. Pablo Zapata Benavides

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2010 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
EMEdgar Mendoza-Gamboa
Edgar Mendoza-Gamboa
CSCrystel Aleyvick Sierra-Rivera
Crystel Aleyvick Sierra-Rivera
RGRicardo Gomez
Ricardo Gomez
PBPablo Zapata Benavides
Pablo Zapata Benavides
CRCristina Rodríguez-Padilla
Cristina Rodríguez-Padilla
Colloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic effects on MCF-7 breast cancer cells and its mechanism of cell death.

22 May 2009 in Cancer Gene Therapy
Verified
Journal Article
Closed access
DZD E Zamora-Avila
D E Zamora-Avila
PBPablo Zapata Benavides
Pablo Zapata Benavides
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
SSS Saavedra-Alonso
S Saavedra-Alonso
LTLaura M. Trejo-Avila
Laura M. Trejo-Avila
CRC Rodríguez-Padilla
C Rodríguez-Padilla

29 May 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
AUAshanti Concepción Uscanga-Palomeque
Ashanti Concepción Uscanga-Palomeque
PBPablo Zapata Benavides
Pablo Zapata Benavides
SSSantiago Saavedra-Alonso
Santiago Saavedra-Alonso
DADiana Elisa Zamora Avila
Diana Elisa Zamora Avila
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
CRCristina Padilla Rodríguez-Padilla
Cristina Padilla Rodríguez-Padilla
Cuphea aequipetala (C. aequipetala) has been used in Mexican traditional medicine since prehispanic times to treat tumors. In this paper, we evaluated the antiproliferative and apoptotic effect of the methanolic and aqueous extracts of C. aequipetala on several cancer cell lines including the B16F10 cell line of murine melanoma and carried a murine model assay. In vitro assay analyzed the effect in the cellular cycle and several indicators of apoptosis, such as the caspase-3 activity, DNA fragmentation, phosphatidylserine exposure (Annexin-V), and induction of cell membrane permeabilization (propidium iodide) in the B16F10 cells. In vivo, groups of C57BL/6 female mice were subcutaneously injected with 5x105 B16F10 cells and treated with 25 mg/mL of C. aequipetala extracts via oral. Aqueous and methanolic extracts showed a cytotoxic effect in MCF-7, HepG2, and B16F10 cell lines. The methanolic extract showed more antiproliferative effect with less concentration, and for this reason, the in vitro experiments were only continued with it. This extract was able to induce accumulation of cells on G1 phase of the cell cycle; moreover, it was able to induce DNA fragmentation and increase the activity of caspase-3 in B16F10 cells. On the other hand, in the murine model of melanoma, the aqueous extract showed a greater reduction of tumor size in comparison with the methanolic extract, showing an 80% reduction versus one of around 31%, both compared with the untreated control, indicating a better antitumor effect of C. aequipetala aqueous extract via oral administration. In conclusion, the in vitro data showed that both C. aequipetala extracts were able to induce cytotoxicity through the apoptosis pathway in B16F10 cells, and in vivo, the oral administration of aqueous extract reduces the melanoma tumoral mass, suggesting an important antitumoral effect and the perspective to search for effector molecules involved in it.

25 October 2021 in In Vivo
Verified
Journal Article
Closed access
PDF file
MAMariela Arellano-Rodríguez
Mariela Arellano-Rodríguez
PBPablo Zapata Benavides
Pablo Zapata Benavides
NANorma Cesilia Arellano-Rodríguez
Norma Cesilia Arellano-Rodríguez
JIJuan Manuel Izaguirre-Álvarez
Juan Manuel Izaguirre-Álvarez
MFMoisés Armides Franco-Molina
Moisés Armides Franco-Molina
CRCristina Rodríguez-Padilla
Cristina Rodríguez-Padilla
Background/Aim: Wilms’ tumor 1 (WT1) is involved in the development of the urogenital system and is expressed in podocytes throughout life. Inflammation of renal glomeruli causes renal damage-induced nephrotic syndrome and steroid-resistant nephrotic syndrome have mutations in the WT1 gene. The aim of this work was to determine if the inflammatory process modulates the expression and localization of WT1 in podocytes that cause kidney damage using lipopolysaccharide (LPS)-treated mice as a sepsis model. Materials and Methods: In investigation of renal damage, proteinuria and histology were analyzed. WT1 modulation was analyzed by indirect immunofluorescence, immunohistochemistry and western blot assays, and proinflammatory cytokines were analyzed by quantitative polymerase chain reaction assay. Results: WT1 expression decreased most at 24 and 36 h after the induction of inflammation and phosphorylated WT1 was mainly localized in the cytoplasm, reduced nephrin mRNA expression and increased mRNA expression of tumor necrosis factor α and interleukin 1β. Conclusion: These results indicate that the immune system plays an important role in the modulation of WT1, leading to kidney damage.

Verified
Journal Article
Open access
PDF file
PFPedro Félix
Pedro Félix
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
DTDIANA ZARATE TRIVIÑO
DIANA ZARATE TRIVIÑO
PGPaola Leonor García
Paola Leonor García
PBPablo Zapata Benavides
Pablo Zapata Benavides
CRCristina Padilla Rodríguez-Padilla
Cristina Padilla Rodríguez-Padilla
Immunogenic cell death (ICD) is a type of cell death capable of stimulating immunity against cancer through danger signals that lead to an adaptive immune response. Silver nanoparticles (AgNPs) have been shown to have a cytotoxic effect on cancer cells; however, their mechanism of action is not fully understood. The present study synthesized, characterized, and evaluated the cytotoxic effect of beta-D-glucose-reduced AgNPs (AgNPs-G) against breast cancer (BC) cells in vitro; and assess the immunogenicity of cell death in vitro and in vivo. The results showed that AgNPs-G induce cell death in a dose-dependent manner on BC cell lines. In addition, AgNPs show antiproliferative effects by interfering with the cell cycle. Regarding the detection of damage-associated molecular patterns (DAMPs), it was found that treatment with AgNPs-G induces calreticulin exposure and the release of HSP70, HSP90, HMGB1, and ATP. In vivo, prophylactic vaccination did not prevent tumor establishment; however, tumor weight was significantly lower in AgNPs-G vaccinated mice, while the survival rate increased. In conclusion, we have developed a new method for the synthesis of AgNPs-G, with in vitro antitumor cytotoxic activity on BC cells, accompanied by the release of DAMPs. In vivo, immunization with AgNPs-G failed to induce a complete immune response in mice. Consequently, additional studies are needed to elucidate the mechanism of cell death that leads to the design of strategies and combinations with clinical efficacy.

19 February 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
PBPablo Zapata Benavides
Pablo Zapata Benavides
MAMariela Arellano-Rodríguez
Mariela Arellano-Rodríguez
JBJuan José Bollain-Y-Goytia
Juan José Bollain-Y-Goytia
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
GRGloria Azucena Rangel-Ochoa
Gloria Azucena Rangel-Ochoa
CRCristina Rodríguez-Padilla
Cristina Rodríguez-Padilla
Nephrotic syndrome (NS) is a glomerular disease that is defined by the leakage of protein into the urine and is associated with hypoalbuminemia, hyperlipidemia, and edema. Steroid-resistant NS (SRNS) patients do not respond to treatment with corticosteroids and show decreased Wilms tumor 1 (WT1) expression in podocytes. Downregulation of WT1 has been shown to be affected by certain microRNAs (miRNAs). Twenty-one patients with idiopathic NS (68.75% were SSNS and 31.25% SRNS) and 10 healthy controls were enrolled in the study. Podocyte number and WT1 location were determined by immunofluorescence, and the serum levels of miR-15a, miR-16-1, and miR-193a were quantified by RT-qPCR. Low expression and delocalization of WT1 protein from the nucleus to the cytoplasm were found in kidney biopsies of patients with SRNS and both nuclear and cytoplasmic localization were found in steroid-sensitive NS (SSNS) patients. In sera from NS patients, low expression levels of miR-15a and miR-16-1 were found compared with healthy controls, but only the miR-16-1 expression levels showed statistically significant decrease (p=0.019). The miR-193a expression levels only slightly increased in NS patients. We concluded that low expression and delocalization from the WT1 protein in NS patients contribute to loss of podocytes while modulation from WT1 protein is not associated with the miRNAs analyzed in sera from the patients.